Top segments and regional performance

Last year, the company generated ‪11.51 B‬ INR, the most of which — ‪12.46 B‬ INR — came from its top-performing segment, Pharmaceuticals, compared to ‪12.30 B‬ INR the previous year. The greatest contribution came from India, which accounted for ‪11.61 B‬ INR last year, with ‪10.96 B‬ INR the year before.